Cargando…
Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) cardiomyopathy is a progressive disease for which there is no cure. Disease-specific therapies are needed that can be initiated before irreversible myocardial damage ensues. In order to evaluate therapeutic efficacy, surrogate endpoints other than ejecti...
Autores principales: | Soslow, Jonathan H., Damon, Stephen M., Crum, Kimberly, Lawson, Mark A., Slaughter, James C., Xu, Meng, Arai, Andrew E., Sawyer, Douglas B., Parra, David A., Damon, Bruce M., Markham, Larry W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722665/ https://www.ncbi.nlm.nih.gov/pubmed/26795569 http://dx.doi.org/10.1186/s12968-016-0224-7 |
Ejemplares similares
-
Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium Eenhancement
por: Soslow, Jonathan H, et al.
Publicado: (2016) -
T1 mapping is abnormal before decline in EF in patients with Becker and Duchenne muscular dystrophy
por: Soslow, Jonathan H, et al.
Publicado: (2013) -
Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy
por: Raucci, Frank J., et al.
Publicado: (2021) -
Left ventricular function by echocardiography correlates poorly with cardiac MRI measures in Duchenne muscular dystrophy
por: Soslow, Jonathan H, et al.
Publicado: (2014) -
Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy
por: Arteaga, David, et al.
Publicado: (2020)